BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Astellas Pharma US 

Agensys, Inc., a subsidiary of Astellas Pharma US
2225 Colorado Avenue
Santa Monica  California  90404  U.S.A.
Phone: 310-820-8029 Fax: 310-382-2802


SEARCH JOBS


Industry
Biotechnology






 Company News
Seattle Genetics, Inc. (SGEN) and Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE), Announce Co-Development of an Additional Antibody-Drug Conjugate (ADC) Under Existing Collaboration 6/27/2013 9:54:41 AM    More...
Agensys, Inc. and Seattle Genetics, Inc. (SGEN) Announce Interim Phase I Data from ASG-5ME Clinical Trial for Prostate Cancer 6/4/2012 10:40:53 AM    More...
Astellas Pharma Inc. (YPH.BE) Adds Two Key Senior Executives at Agensys, Inc. 12/1/2011 3:02:21 PM    More...
Seattle Genetics, Inc. (SGEN) and Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE), Announce Co-Development of Second Antibody-Drug Conjugate (ADC) Under Existing Collaboration 6/9/2011 9:27:27 AM    More...
Agensys, Inc. Announces Retirement of Donald Rice and Appointment of Sef Kurstjens as CEO and President 11/2/2010 7:14:41 AM    More...
Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE), and Seattle Genetics, Inc. (SGEN) Announce Initiation of Phase I Clinical Trial of ASG-5ME for Prostate Cancer 10/20/2010 10:27:54 AM    More...
Seattle Genetics, Inc. (SGEN) Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE) 9/2/2010 10:44:59 AM    More...
Seattle Genetics, Inc. (SGEN) Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE); Seattle Has Received $130 Million to date With Potential to Receive $2.7 Billion 9/2/2010 7:43:55 AM    More...
Agensys, Inc. Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer 9/1/2010 8:18:50 AM    More...
Seattle Genetics, Inc. (SGEN) and Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE), Announce Initiation of Phase I Clinical Trial of ASG-5ME for Pancreatic Cancer 7/20/2010 8:07:24 AM    More...
123

//-->